高压氧治疗COVID-19后视神经炎1例及文献分析

doi:10.6040/j.issn.1673-3770.0.2023.277

摘要/Abstract

摘要： 目的为新型冠状病毒肺炎感染后视神经炎的早期视力挽救提供新的临床治疗方法和策略。方法回顾性分析3例COVID-19感染后视神经炎患者的临床资料并复习相关文献。结果 COVID-19感染无论是在急性期还是在随后的恢复期都会对感染患者视网膜和视神经产生影响,本研究的3例病例常规药物治疗后视力恢复较差,其中1例接受联合高压氧治疗后视力恢复明显、近期与远期视力恢复程度完全。结论 COVID-19感染后视神经炎并不罕见,及时早期联合高压氧干预治疗COVID-19感染后视神经炎疗效更快、更优,对此类患者尽快恢复视力、防止不可逆转的视力丧失具有重要意义,值得临床重视和推广。

关键词: 新型冠状病毒肺炎, 视神经炎, 高压氧, 视力, 激素

Abstract: Objective This study aims to provide a new clinical treatment method and strategy for early vision rescue of optic neuritis after COVID-19 infection. Methods The clinical data of three patients with optic neuritis after COVID-19 infection were retrospectively analyzed, and the related literature was reviewed. Results COVID-19 infection affects the retina and optic nerve of patients in the acute and subsequent recovery stages. In this study, three patients demonstrated poor vision recovery after conventional drug treatment. Among them, one patient received combined hyperbaric oxygen therapy, the vision recovery was significantly faster, and the short- and long-term vision recovery was complete. Conclusion Optic neuritis after COVID-19 infection is common. Enhancing early vision rescue with hyperbaric oxygen intervention in the treatment of optic neuritis after COVID-19 infection is an effective and better approach. Immediate vision restoration and prevention of irreversible vision loss in these patients, carry immense clinical significance and merit promotion.

Key words: COVID-19, Optic neuritis, Hyperbaric oxygen, Vision, Hormone

中图分类号:

R563.1

王磊,王学艺,田艳娟,匡爱华,段小妮,赵寅. 高压氧治疗COVID-19后视神经炎1例及文献分析[J]. 山东大学耳鼻喉眼学报, 2024, 38(5): 100-104.

WANG Lei, WANG Xueyi, TIAN Yanjuan, KUANG Aihua, DUAN Xiaoni, ZHAO Yin. Hyperbaric oxygen therapy for optic neuritis after COVID-19: a case report and literature analysis[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(5): 100-104.

参考文献

[1] World Health Organization.Drugs to prevent COVID-19: living guideline[DB/OL].[2023-5-21].https://www.who.int/publications/i/item/WHO-2019-nCoV-prophylaxes-2023.1
[2] Ballering A, van Zon SV, Olde Hartman TO, et al. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study[J]. Lancet Lond Engl, 2022, 400: 452-461. doi:10.1016/S0140-6736(22)01214-4
[3] Zawilska JB, Kuczyńska K. Psychiatric and neurological complications of long COVID[J]. J Psychiatr Res, 2022, 156: 349-360. doi:10.1016/j.jpsychires.2022.10.045
[4] Soriano JB, Murthy S, Marshall JC, et al. A clinical case definition of post-COVID-19 condition by a Delphi consensus[J]. Lancet Infect Dis, 2022, 22(4): e102-e107. doi:10.1016/S1473-3099(21)00703-9
[5] Cevallos MAV, Vásquez AM. Alteraciones en el nervio óptico y retina en pacientes con COVID-19, Una revisión teórica [J]. Arch Soc Esp Oftalmol, 2023. doi:10.1016/j.oftal.2023.06.002
[6] Sen M, Honavar SG, Sharma N, et al. COVID-19 and eye: a review of ophthalmic manifestations of COVID-19[J]. Indian J Ophthalmol, 2021, 69(3): 488-509. doi:10.4103/ijo.IJO_297_21
[7] Duran M, Aykaç S. Optic neuritis after COVID-19 infection: a case report[J]. J Francais D'ophtalmologie, 2022, 46: 4-7. doi:10.1016/j.jfo.2022.09.005
[8] Ally N, Alli HD, Jeeva-Patel T, et al. Optic neuritis: a South African hospital-based prospective study protocol[J]. PLoS ONE, 2022, 17(6):0269514. doi:10.1371/journal.pone.0269514
[9] 中华医学会眼科学分会神经眼科学组. 视神经炎诊断和治疗专家共识(2014年)[J]. 中华眼科杂志, 2014(6): 459-463. doi: 10.3760/cma.j.issn.0412-4081.2014.06.013
[10] Azab MA, Hasaneen SF, Hanifa H, et al. Optic neuritis post-COVID-19 infection. a case report with meta-analysis[J]. Interdiscip Neurosurg. 2021, 26(10):101320. doi: 10.1016/j.inat.2021.101320
[11] Sainath D, Paul A, Krishnagopal S, et al. Acute bilateral retrobulbar optic neuritis - An atypical sequela of COVID-19[J]. Indian J Ophthalmol, 2021, 69(12):3761-3764. doi: 10.4103/ijo.IJO_2155_21
[12] Jossy A, Jacob N, Sarkar S, et al. COVID-19-associated optic neuritis - A case series and review of literature[J]. Indian J Ophthalmol, 2022, 70(1): 310-316. doi:10.4103/ijo.IJO_2235_21
[13] Sawalha K, Adeodokun S, Kamoga GR. COVID-19-induced acute bilateral optic neuritis[J]. J Investig Med High Impact Case Rep, 2020, 8:2324709620976018. doi: 10.1177/2324709620976018
[14] Zhou SW, Jones-López E, Soneji D, et al. Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis and myelitis in COVID-19[J]. 2020, 40(3):398-402. doi: 10.1097/WNO.0000000000001049
[15] Kogure C, Kikushima W, Fukuda Y, et al. Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis in a COVID-19 patient: a case report[J]. Medicine, 2021, 100(19): 25865. doi:10.1097/MD.0000000000025865
[16] Gold DM, Galetta SL. Neuro-ophthalmologic complications of coronavirus disease 2019(COVID-19)[J]. Neurosci Lett, 2021, 742: 135531. doi:10.1016/j.neulet.2020.135531
[17] Abdul-Salam State SE, Sfredel V, Mocanu CL, et al. Optic neuropathies post-Covid 19-review[J]. Romanian Journal of Ophthalmology, 2022, 66(4): 289-298. doi:10.22336/rjo.2022.54
[18] Shapira R, Solomon B, Efrati S, et al. Hyperbaric oxygen therapy ameliorates pathophysiology of 3xTg-AD mouse model by attenuating neuroinflammation[J]. Neurobiol Aging, 2018, 62: 105-119. doi:10.1016/j.neurobiolaging.2017.10.007
[19] Benson RM, Minter LM, Osborne BA, et al. Hyperbaric oxygen inhibits stimulus-induced proinflammatory cytokine synthesis by human blood-derived monocyte-macrophages[J]. Clin Exp Immunol, 2003, 134(1): 57-62. doi:10.1046/j.1365-2249.2003.02248.x
[20] Gottfried I, Schottlender N, Ashery U. Hyperbaric oxygen treatment-from mechanisms to cognitive improvement[J]. Biomolecules, 2021, 11(10): 1520. doi:10.3390/biom11101520
[21] Shai E, Eshel BJ. Reflections on the neurotherapeutic effects of hyperbaric oxygen[J]. Expert Rev Neurother, 2014, 14(3): 233-236. doi:10.1586/14737175.2014.884928
[22] 曹锦泉, 张绪中. 高压氧—二氧化碳混合气治疗急性视神经炎31例的疗效[J]. 中华航海医学杂志, 1995(3): 54-55. doi: 10.3760/cma.j.issn.1005-3506.1995.03.126
[23] 高承兰, 毕竹梅. 高压氧治疗急性视神经炎的疗效观察[J]. 山东大学基础医学院学报, 2002, 16(4):230-231. doi: 10.3969/j.issn.1673-3770.2002.04.018 GAO Chenglan, BI Zhumei. Hyperbaric oxygenation on acute optic neuritis[J]. Journal of Preclinical Medicine College of Shandong Medical University, 2002, 16(4):230-231. doi: 10.3969/j.issn.1673-3770.2002.04.018
[24] 刘秀明, 王曙红, 王文奇. 高压氧联合复方樟柳碱治疗急性视神经炎疗效观察[J]. 海南医学, 2013, 24(9):1367-1368. doi: 10.3969/j.issn.1003-6350.2013.09.0575 LIU Xiuming, WANG Shuhong, WANG Wenqi. Clinical effect of hyperbaric oxygen combined with compound anisodine in the treatment of acute optic neuritis[J]. Hainan Medical Journal, 2013, 24(9):1367-1368. doi: 10.3969/j.issn.1003-6350.2013.09.0575
[25] 张志广, 朱海清. 高压氧二氧化碳混合气在急性视神经炎临床治疗中的效果[J]. 中国实用神经疾病杂志, 2015(22): 7-8. doi:10.3969/j.issn.1673-5110.2015.22.004 ZHANG Zhiguang, ZHU Haiqing. Clinical application effect of hyperbaric oxygen and carbon dioxide mixture in the treatment of acute optic neuritis[J]. Chinese Journal of Practical Nervous Diseases, 2015(22): 7-8. doi:10.3969/j.issn.1673-5110.2015.22.004

相关文章 15

[1]	陈兴雪,张广玲,武天义,王卫卫,孙占伟,李世超,王广科. 抗IL-4Rα单克隆抗体与鼻内镜手术治疗嗜酸性粒细胞型慢性鼻窦炎伴鼻息肉的疗效分析[J]. 山东大学耳鼻喉眼学报, 2024, 38(4): 43-54.
[2]	李姗姗,甘春兰,朱俊,华欣,陈放. 胸椎手术后双眼后部缺血性视神经病变1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2024, 38(4): 131-134.
[3]	李淑婷,赵慧,司明威,崔文轩,杨梦瑶,王红. 无植物性外伤史患者感染真菌性眼内炎1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2024, 38(2): 103-108.
[4]	邓宇,王建伟,刘自强,李媛媛,侯小玉,接传红. 中心视力下降患者优选注视点应用的研究进展[J]. 山东大学耳鼻喉眼学报, 2024, 38(2): 150-155.
[5]	王丽雪,曾毅,王丽欣,彭先兵. 浸润毕罗芬明胶海绵在功能性鼻内镜鼻窦手术后应用效果的临床观察[J]. 山东大学耳鼻喉眼学报, 2023, 37(5): 16-25.
[6]	李聪,李玲,刘亭彦, 陈良. 氨基糖苷类抗生素耳毒性影响因素研究进展[J]. 山东大学耳鼻喉眼学报, 2023, 37(2): 128-134.
[7]	孙璐,张顺华,吴昱舟,陈露璐,曹迪,干霖洋. 关于Alpha角0.5~0.8 mm的患者植入区域折射型人工晶状体的短期临床观察[J]. 山东大学耳鼻喉眼学报, 2022, 36(6): 32-37.
[8]	王茜,刘娜,王少鹏. Leber特发性星芒状视神经视网膜炎1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2022, 36(6): 106-110.
[9]	许嘉, 李欣, 陈雯婧, 高娟娟, 卢星星, 伊海金. 联合应用内淋巴囊减压和局部激素治疗难治性梅尼埃病的短期与长期疗效分析[J]. 山东大学耳鼻喉眼学报, 2022, 36(4): 17-21.
[10]	王欢,胡俐,余洪猛. 慢性鼻窦炎相关嗅觉功能障碍研究进展[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 43-49.
[11]	资昊坤,肖旭平,李云秋. 口服糖皮质激素在慢性鼻窦炎伴鼻息肉围手术期的应用现状[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 98-103.
[12]	陈世琴,卫平存,胡云龙,胡金旺. 糖皮质激素三种不同鼻用法对鼻内镜术后黏膜转归的影响[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 195-201.
[13]	龚霄阳,程雷. 新冠疫情期间基于门诊患者的变应性鼻炎患者比例构成分析[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 245-255.
[14]	钟丽萍,官希龙,王晶晶,汤勇. 鼓室与全身应用激素治疗突发性耳聋的系统评价与Meta分析[J]. 山东大学耳鼻喉眼学报, 2021, 35(5): 1-10.
[15]	庄佩耘,刘昀逸. 内分泌激素与嗓音[J]. 山东大学耳鼻喉眼学报, 2021, 35(3): 5-9.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed